Signature Diagnostics Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board

05-Oct-2010 - Germany

Signature Diagnostics AG announced the appointment of Rainer Kramer as Chief Business Officer. Dr. Kramer previously held the position of Vice President Corporate Business Development at Jerini AG, where he was responsible for all licensing, partnering, and alliance management activities. Before joining Jerini, he performed various research and business development functions at MorphoSys AG, Martinsried, and Amgen Inc., Thousand Oaks.

Dr. Kramer holds a Diploma in Molecular Biology and a Ph.D from the Max-Planck-Institute for Neurobiology. Throughout his career in corporate business development, he contributed or delivered numerous strategic partnerships and license deals encompassing technology platform and product deals as well as equity transactions with an aggregate value of several hundred million Euros. As a member of Jerini's M&A committee, he was instrumental in the sale of Jerini to Shire in 2008 and was Shire's appointed principal for the sale of JPT GmbH in 2009.

https://www.analytica-world.com/en/news/123818/signature-diagnostics-appoints-rainer-kramer-to-chief-business-officer-and-member-of-the-management-board.html

Topics

molecular biology

Show all

Organizations

Signature Diagnostics

Under the magnifying glass: The world of microscopy

Microscopy News

Last viewed contents

AB SCIEX Collaborates with Major German Water Supply Company to Improve Identification of Contaminants in Drinking Water

Go to page

Wavelength dispersive X-ray fluorescence spectrometry for the assessment of lead concentration in animal bone powder

Go to page

Healthcare is up for a Revolution with the Rise of Personal Genomic Tests - Frost & Sullivan finds that direct to consumer genomics, which were close to absent a decade ago, are currently thriving

Go to page

Varian, Inc. Named 2004 Analytical Instrumentation Company of the Year by Frost & Sullivan

Go to page

Sticky stuff: Jacobs researchers reveal the sweet secret of caramel

Go to page

Affibody to start clinical development of a approach for the diagnosis of cancer - Swedish MPA gives go ahead for the clinical trial of Affibody's molecular imaging agent designed to improve the diagnosis of HER2-positive breast cancer.

Go to page

Galapagos wins 2011 Scrip Award for Biotech Company of the Year

Go to page

Drug Discovery Companies Focus on Strong Product Line to Offset R&D Budget Slowdown

Go to page

Many researchers are familiar with the problem: Before there are any new findings, there is an unknown measuring device - "SweepMe!" simplifies the use of measuring devices

Go to page

SeraCare Life Sciences Introduces New Executives Company Supports Growth of Precision Medicine

Go to page

Symyx Appoints New President of High Productivity Research

Go to page

Structure of Human Cytochrome P450 2D6 solved by GlaxoSmithKline with the use of Fludigm Technology

Go to page

More from the department people Subscribe to newsletter

Signature Diagnostics Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board

febit Appoints Jack Leonard, Ph.D., Vice President of Technology Commercialization

Other news from the department people

Change in Management at Shimadzu in Germany

New Managing Director for Shimadzu Europa GmbH

NIS and Proteos launch TrueCourse Biosciences

Nuclera appoints Thermo Fisher Scientific manager as its new CEO

Danish 3D cell culture company Celvivo raises USD 6.6 million and appoints new CEO for global scale-up

QIAGEN appoints Jonathan M. Pratt as CEO

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific

Danaher appoints Julie Sawyer Montgomery as president and chief executive officer

Gradientech appoints Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growth

Shimadzu acquires European electron microscopy pioneer for $711 million

Change at TOPTICA Executive Board

2026 Future Insight Prize Goes to Spear’s Vasilis Ntziachristos

hte is getting a dual leadership structure: Denis Hürtgen and Michael Paul take over leadership

Merck Appoints New Heads of Discovery Solutions and Strategy & BD for Life Science

Atrandi Biosciences fills key roles to support global market expansion

Alexandra Knauer mit Pittcon Heritage Award ausgezeichnet

Change of management at abberior instruments

trinamiX with new management

Die Köttermann Group appoints Joerg Hoffmann as CEO

NanoTemper Introduces New Executive Leadership Team to Advance Biophysical Innovation

Most read news

Two new bioinformatics tools improve the diagnosis of genetic disorders

A blood test can detect over 50 types of cancer

New Managing Director for Shimadzu Europa GmbH

Electronic nose detects whether meat and fish are still safe to eat

AI scientist autonomously generates and validates new biological discoveries

Automated Lab Speeds Up Material Development

Claude discovers a novel enzyme system with CRISPR-like repeats

Protein Content in Foods — New Conversion Factors Enable More Precise Assessment

When molecules »notice« what their neighbours are doing

On the trail of dissolution: Only 30 water molecules separate salt

Weeks of Work in a Few Hours: AI Tool Reads Cell Membranes

Altmann Analytik Acquires Laboratory Supplier Kobe

More news from our other portals

Tavion raises €50 million and starts development of its first battery parks in Polan

New method causes cancer cells to burn out

Arla is investing more than 63 million euros in the future of high-protein dairy products

Two chemical giants, a potential deal: BASF and Evonik in talks

A tiny bacterium with a huge impact

AI as a Tool in Flavor Research: De Novo Design of Bitter Peptides

Evonik is cutting 3,200 jobs worldwide and sharpens growth strategy

BII allocates 8 million euros to further support six promising companies

Energy Drinks: Consumption Is Rising Among Schoolchildren

Recycling in Agriculture: Biogenic CO₂ Is Turned Into Renewable Fuel

Age-related diseases can be reduced through health check-ups

75 percent of Gen Z buy protein products—social media is driving the trend among Gen Z

Rapeseed oil instead of crude oil: Verbio starts industrial production of renewable chemicals

Sandoz invests in new drug substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity

Ammeraal Beltech to Present Food Conveyor Solutions at EHEDG World Congress

How a deep-sea microorganism breaks toughest chemical bonds

Mould toxins in food are not destroyed during cooking or baking

Healthy eating slows biological aging – regardless of diet

Silicon anodes from Groningen: US start-up GDI builds demonstration factory to cut China dependency

Revvity to acquire France-based biotechnology company

New Leadership for Danone in Germany, Austria, and Switzerland

Europe’s last Acetyls site halts production

BioNTech Founders Launch New Venture

No evidence that sugar substitutes harm weight, health, or sweet taste preferences

Enzymes in Beads for a More Sustainable Chemistry

Europe Secures Insulin Supply: New Production Facility Planned in Frankfurt-Höchst

Can this biotech innovation halt the destructive march of a cereal killer?

64% of Germany's plastic waste is incinerated instead of being recycled

GSK Plans to Close Its Vaccine Plant in Dresden

Climate-driven water scarcity increases wheat prices globally

Under the magnifying glass: The world of microscopy

Last viewed contents

AB SCIEX Collaborates with Major German Water Supply Company to Improve Identification of Contaminants in Drinking Water

Wavelength dispersive X-ray fluorescence spectrometry for the assessment of lead concentration in animal bone powder

Healthcare is up for a Revolution with the Rise of Personal Genomic Tests - Frost & Sullivan finds that direct to consumer genomics, which were close to absent a decade ago, are currently thriving

Varian, Inc. Named 2004 Analytical Instrumentation Company of the Year by Frost & Sullivan

Sticky stuff: Jacobs researchers reveal the sweet secret of caramel

Affibody to start clinical development of a approach for the diagnosis of cancer - Swedish MPA gives go ahead for the clinical trial of Affibody's molecular imaging agent designed to improve the diagnosis of HER2-positive breast cancer.

Galapagos wins 2011 Scrip Award for Biotech Company of the Year

Drug Discovery Companies Focus on Strong Product Line to Offset R&D Budget Slowdown

Many researchers are familiar with the problem: Before there are any new findings, there is an unknown measuring device - "SweepMe!" simplifies the use of measuring devices

SeraCare Life Sciences Introduces New Executives Company Supports Growth of Precision Medicine

Symyx Appoints New President of High Productivity Research